BH

Benny Helen Raju

Active Director Additional Director DIN 10817616
DIN 10817616 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Benny Helen Raju

Data last updated:

Benny Helen Raju is an Additional Director at Waymed Diabetic & Critical Care Private Limited (since 2024).

DIN 10817616
Primary Designation Additional Director
First Appointment 06 Dec 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director06 Dec 20242023Active

Directorship timeline

Open interactive timeline →
Waymed Diabetic & Critical Care Private Limited
Premium access

Shareholding and investment profile for Benny Helen Raju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Benny Helen Raju

Benny Helen Raju currently holds 1 directorship: Waymed Diabetic & Critical Care Private Limited (Additional Director, since 06 Dec 2024).

Benny Helen Raju was first appointed on 06 Dec 2024 as Additional Director at Waymed Diabetic & Critical Care Private Limited.

The current boards of Benny Helen Raju's companies include Karuppath Binoy (Waymed Diabetic & Critical Care Private Limited), Krishna Prasad (Waymed Diabetic & Critical Care Private Limited), Ramesh (Waymed Diabetic & Critical Care Private Limited), Sujeesh Kurumthottikkal (Waymed Diabetic & Critical Care Private Limited), Vinod (Waymed Diabetic & Critical Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available